Search research articles
Contact Us
Filters
Showing results (221-230 of 251) with videos related to
Page
of 26
Sort By:
Neuro-Oncology
|
March 8, 2026
Oncolytic Adenoviral Infection of Chordoma Achieves Treatment Efficacy Associated with Immunologic Response and Tumor Microenvironmental Alteration
Xizi Wu, Daniel Ledbetter, Jen-Wei Tsai, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 10, 2025
Recurrent <i>ERBB2</i> alterations are associated with esophageal adenocarcinoma brain metastases
Nora M Lawson, Lingqun Ye, Chae Yun Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies
Erik H P van Putten, Anne Kleijn, Victor W van Beusechem, et al.
JCI Insight
|
July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration
Martina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial
Shiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.
Journal of Proteome Research
|
November 5, 2014
Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome
Carol L Nilsson, Ekaterina Mostovenko, Cheryl F Lichti, et al.
The Journal of Clinical Investigation
|
December 25, 2010
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma
Fernanda I Staquicini, Michael G Ozawa, Catherine A Moya, et al.
The Lancet. Oncology
|
July 9, 2017
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial
Anita Mahajan, Salmaan Ahmed, Mary Frances McAleer, et al.
Neuro-Oncology
|
August 10, 2024
Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas
Pravesh Gupta, Minghao Dang, Shivangi Oberai, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 251) with videos related to
Sort By:
Page
of 26
Neuro-Oncology
|
March 8, 2026
Oncolytic Adenoviral Infection of Chordoma Achieves Treatment Efficacy Associated with Immunologic Response and Tumor Microenvironmental Alteration
Xizi Wu, Daniel Ledbetter, Jen-Wei Tsai, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 10, 2025
Recurrent <i>ERBB2</i> alterations are associated with esophageal adenocarcinoma brain metastases
Nora M Lawson, Lingqun Ye, Chae Yun Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies
Erik H P van Putten, Anne Kleijn, Victor W van Beusechem, et al.
JCI Insight
|
July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration
Martina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial
Shiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.
Journal of Proteome Research
|
November 5, 2014
Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome
Carol L Nilsson, Ekaterina Mostovenko, Cheryl F Lichti, et al.
The Journal of Clinical Investigation
|
December 25, 2010
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma
Fernanda I Staquicini, Michael G Ozawa, Catherine A Moya, et al.
The Lancet. Oncology
|
July 9, 2017
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial
Anita Mahajan, Salmaan Ahmed, Mary Frances McAleer, et al.
Neuro-Oncology
|
August 10, 2024
Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas
Pravesh Gupta, Minghao Dang, Shivangi Oberai, et al.
Page
of 26